Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.510 | moderate | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.500 | None | 0.952 | 21 | 7 | 2010 | 2019 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.400 | None | 0.667 | 16 | 0 | 1998 | 2011 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.370 | None | 0.800 | 7 | 0 | 2000 | 2004 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.310 | limited | 1.000 | 2 | 0 | 2016 | 2019 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2018 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.300 | limited | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.300 | limited | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2013 | 2018 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.040 | None | 1.000 | 4 | 2 | 2010 | 2014 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2011 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2016 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2018 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2019 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.020 | None | < 0.001 | 2 | 0 | 2001 | 2001 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.020 | None | < 0.001 | 2 | 0 | 2001 | 2001 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2018 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2016 | ||||||||
|
potassium calcium-activated channel subfamily N member 3 | 0.621 | 0.615 | 0.97 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2004 |